A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation
Clinical trial NCT06625333 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06625333
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-11
- Primary completion
- 2027-12-31
- Enrollment
- 329
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.